2020 Scientific Sessions

Hypercoagulability and Antithrombotic Recommendations During the COVID-19 Pandemic

This activity is supported by an unrestricted educational grant from AstraZeneca. No in-kind commercial support was received.
Case: Thrombotic and Thromboembolic Cardiac Complications, The U.S. Experience
Binita Shah, M.D., FSCAI, NYU Grossman School of Medicine, New York, NY
Potential Mechanisms of COVID Hypercoagulopathy
Joshua Beckman, MD, MSc, Brigham and Women's Hospital, Nashville, TN
Unintended Consequences of Stay-at-Home Orders: Cardiac Events in Non-COVID Patients
Cindy L. Grines, M.D., MSCAI, Northside Hospital Cardiovascular Institute, Johns Creek, GA
See more of: Satellite Sessions